Cardica Receives 510(k) clearance for CABG system

The FDA has granted Cardica 510(k) clearance to market its PAS-Port proximal anastomosis system for use in CABG.

The PAS-Port system creates a secure connection, or anastomosis, between a vein graft and the aorta during CABG procedures, according to the Redwood City, Calif.-based company. Currently available in Japan and Europe, where it has been used more than 8,800 times, the PAS-Port system is now commercially available by Cardica in the U.S.

Cardica said that its PAS-Port system allows a surgeon to complete an automated proximal anastomosis without the need to clamp and manipulate the aorta, which could reduce the risk of particle release and ensuing neurocognitive events.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.